PSYCHEMEDICS CORP
PSYCHEMEDICS CORP
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 4 | 5 | 3 | 2 | 2 | |||||
Accounts Receivable Net Current | 3 | 3 | 3 | 4 | 4 | 5 | 4 | 4 | 4 | 5 | 4 | 5 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | |||||
Income Taxes Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 3 | 3 | |||||
Assets Current | 5 | 6 | 6 | 6 | 7 | 8 | 8 | 10 | 10 | 11 | 11 | 11 | |||||
Property Plant And Equipm… | |||||||||||||||||
Capitalized Computer Software Gross | 6 | - | - | - | 5 | - | - | - | 5 | - | - | - | |||||
Furniture And Fixtures Gross | 2 | - | - | - | 2 | - | - | - | 2 | - | - | - | |||||
Leasehold Improvements Gross | 4 | - | - | - | 4 | - | - | - | 4 | - | - | - | |||||
Property Plant And Equipment Gross | 24 | 2 | 3 | 3 | 27 | 3 | 4 | 4 | 27 | 5 | 6 | 6 | |||||
Accumulated Depreciation Depletion And Amortizatio… | -22 | 22 | 22 | 24 | -24 | 23 | 23 | 22 | -22 | 0 | 21 | 20 | |||||
Property Plant And Equipment Net | 2 | - | - | - | 3 | - | - | - | 5 | - | - | - | |||||
Other Assets Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Deferred Income Tax Assets Net | - | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | |||||
Finance Lease Right Of Use Asset | 0 | 0 | - | - | 0 | - | - | - | - | - | - | - | |||||
Assets | 8 | 10 | 10 | 11 | 12 | 14 | 16 | 18 | 19 | 20 | 20 | 21 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | |||||
Accrued Liabilities Current | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 4 | 4 | 3 | 3 | |||||
Short Term Bank Loans And Notes Payable | 0 | 0 | 1 | - | 0 | - | - | - | - | - | - | - | |||||
Long Term Debt Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Finance Lease Liability Current | 0 | 0 | - | - | 0 | - | - | - | - | - | - | - | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Long Term Debt Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |||||
Deferred Income Tax Liabilities Net | - | - | - | - | - | 0 | - | - | - | - | 0 | - | |||||
Liabilities Current | 3 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 6 | 5 | 5 | |||||
Operating Lease Liability Noncurrent | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 3 | |||||
Finance Lease Liability Noncurrent | 0 | 0 | - | - | 0 | - | - | - | - | - | - | - | |||||
Liabilities | 3 | 4 | 4 | 5 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 9 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 35 | 36 | 36 | 35 | 35 | 35 | 35 | 34 | 34 | 34 | 34 | 34 | |||||
Treasury Stock Value | -10 | -10 | -10 | -10 | -10 | -10 | -10 | -10 | -10 | -10 | -10 | -10 | |||||
Retained Earnings Accumulated Deficit | -19 | -19 | -18 | -17 | -17 | -16 | -14 | -13 | -12 | -11 | -10 | -10 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | |||||
Stockholders Equity | 5 | 5 | 6 | 6 | 7 | 7 | 9 | 10 | 11 | 12 | 12 | 12 | |||||
Liabilities And Stockholders Equity | 8 | 10 | 10 | 11 | 12 | 14 | 16 | 18 | 19 | 20 | 20 | 21 | |||||
Allowance For Doubtful Accounts Receivable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.005 | 0.005 | - | 0.01 | 0.005 | 0.005 | 0.005 | 0.01 | 0.005 | 0.005 | 0.005 | |||||
Preferred Stock Shares Authorized | 1 | 1 | 1 | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | - | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.005 | 0.005 | 0.005 | 0.01 | 0.005 | 0.005 | 0.005 | 0.01 | 0.005 | 0.005 | 0.005 | |||||
Common Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | |||||
Common Stock Shares Issued | 7 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |||||
Shares Outstanding | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | |||||
Treasury Stock Common Shares | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | - | |||||
Treasury Stock Shares | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -15.09% | -8.30% | -24.53% | -2.15% | -0.86% | -0.43% | 36.52% | -14.94% | -7.71% | 4.52% | 6.79% | 0.00% |
| 2023 | -4.97% | -8.77% | -0.17% | -18.85% | -35.45% | -51.84% | 28.07% | 64.47% | 38.16% | -12.29% | -11.95% | -23.21% |
| 2022 | 1.27% | 0.78% | 3.07% | -0.80% | -0.19% | -0.49% | -7.02% | -20.63% | -10.10% | 2.64% | -4.07% | -9.90% |
| 2021 | - | - | - | - | - | - | - | - | - | -3.62% | -5.65% | -8.41% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 1.82 | 1.59 | 1.60 | 1.48 | 1.45 | 1.46 | 1.46 | 1.65 | 1.74 | 1.74 | 2.06 | 1.98 | |||||
| Quick Ratio | 1.45 | 1.25 | 1.20 | 1.27 | 1.20 | 1.18 | 1.14 | 1.46 | 1.54 | 1.49 | 1.73 | 1.78 | |||||
| Working Capital | 2.23M | 2.25M | 2.26M | 2.00M | 2.10M | 2.49M | 2.59M | 3.75M | 4.25M | 4.55M | 5.61M | 5.20M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.62 | 0.81 | 0.76 | 0.78 | 0.85 | 0.90 | 0.80 | 0.76 | 0.74 | 0.75 | 0.71 | 0.68 | |||||
| Debt Ratio | 0.38 | 0.45 | 0.43 | 0.44 | 0.46 | 0.47 | 0.44 | 0.43 | 0.42 | 0.43 | 0.42 | 0.41 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.91 | 1.69 | 1.57 | 1.49 | 1.42 | 1.32 | 1.28 | 1.27 | 1.25 | 1.18 | 1.16 | 1.13 | |||||
| Days Sales Outstanding TTM | 57.36 | 71.36 | 61.97 | 67.11 | 61.33 | 76.42 | 64.96 | 65.03 | 56.80 | 67.69 | 58.50 | 61.94 | |||||
| Receivables Turnover TTM | 6.36 | 5.12 | 5.89 | 5.44 | 5.95 | 4.78 | 5.62 | 5.61 | 6.43 | 5.39 | 6.24 | 5.89 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.32 | - | - | - | -0.72 | - | - | - | -0.19 | - | - | - | |||||
| Free Cash Flow Per Share TTM | 0.15 | 0.08 | -0.14 | -0.32 | -0.29 | -0.08 | 0.50 | 0.72 | 0.84 | 0.54 | 0.10 | 0.16 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.27 | 0.41 | 0.42 | 0.76 | 0.55 | 0.49 | 0.49 | 0.17 | 0.11 | 0.04 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 36.07% | 38.36% | 37.63% | 38.57% | 38.07% | 37.71% | 37.44% | 36.82% | 36.81% | 35.54% | 38.17% | 39.44% | |||||
| Operating Profit Margin TTM | -9.62% | -14.46% | -16.56% | -13.71% | -13.22% | -10.56% | -7.10% | -6.51% | -4.29% | -6.51% | -1.79% | 0.32% | |||||
| Net Profit Margin TTM | -9.45% | -14.78% | -21.93% | -20.64% | -18.80% | -17.09% | -8.02% | -6.13% | -4.29% | -7.77% | -4.52% | -2.76% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | -10.92% | -11.16% | -11.98% | -12.18% | -12.45% | -12.20% | -9.62% | -4.33% | 1.33% | 9.09% | 17.13% | 31.57% | |||||
| Net Income Growth (1Y) | -55.20% | -23.15% | 140.58% | 195.82% | 283.21% | 93.21% | 60.46% | 112.55% | 63.01% | -588.38% | -17.59% | -80.40% | |||||
| EPS Growth (1Y) | -56.17% | -24.96% | 136.32% | 189.65% | 275.60% | 111.94% | 76.74% | 134.01% | 60.78% | -580.41% | -18.70% | -80.57% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -7.06 | -4.57 | -3.10 | -3.83 | -4.11 | -5.89 | -13.82 | -19.62 | -24.87 | -19.50 | -32.30 | -57.58 | |||||
| P/B TTM | 2.56 | 2.51 | 2.46 | 2.72 | 2.56 | 3.09 | 2.87 | 2.91 | 2.50 | 3.36 | 3.20 | 3.28 | |||||
| P/S TTM | 0.67 | 0.68 | 0.68 | 0.79 | 0.77 | 1.01 | 1.11 | 1.20 | 1.07 | 1.51 | 1.46 | 1.59 | |||||
| Market Cap | 13.14M | 13.68M | 14.15M | 17.09M | 17.07M | 22.96M | 26.18M | 29.57M | 26.96M | 39.33M | 38.14M | 40.83M | |||||
| Enterprise Value | 11.81M | 12.44M | 12.87M | 15.90M | 15.41M | 21.97M | 24.19M | 25.71M | 22.81M | 36.61M | 37.27M | 39.79M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 878.00K | 493.00K | -810.00K | -1.87M | -1.64M | -483.00K | 2.85M | 4.12M | 4.70M | 3.39M | 660.00K | 987.00K | |||||
| Net Debt | -1.34M | -1.24M | -1.28M | -1.19M | -1.66M | -991.00K | -1.99M | -3.85M | -4.15M | -2.72M | -876.00K | -1.04M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
PSYCHEMEDICS CORP (PMDI) — SEC Financial Statements & Analysis
PSYCHEMEDICS CORP (PMDI) is a services-medical laboratories company, incorporated in DE. PSYCHEMEDICS CORP trades on OTC as: PMDI. Based on its latest SEC filing (Form 10-Q, period ending 2024-12-31), PSYCHEMEDICS CORP reported a -10.92% year-over-year revenue growth, a Gross Profit Margin of 36.07% (TTM), a Debt-to-Equity ratio of 0.62x, a Price-to-Sales (P/S) ratio of 0.67x (TTM), a Price-to-Book (P/B) ratio of 2.56x (TTM), at a market cap of $13.14M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -10.92%
- Gross Profit Margin TTM
- 36.07%
- Debt To Equity
- 0.62x
- P/S TTM
- 0.67x
- P/B TTM
- 2.56x
- Market Cap
- $13.14M
Data as of 2024-12-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is PSYCHEMEDICS CORP in?
PSYCHEMEDICS CORP (PMDI) operates in the Services-Medical Laboratories industry.
What is PMDI's market cap?
PSYCHEMEDICS CORP (PMDI) has a market capitalization of $13.14M as of 2024-12-31.
What exchange does PMDI trade on?
PSYCHEMEDICS CORP (PMDI) trades on the OTC.
Where is PSYCHEMEDICS CORP incorporated?
PSYCHEMEDICS CORP is incorporated in DE.